Dyne Therapeutics CEO Josh Brumm's 2023 pay jumps 38% to $6M
Dyne Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 5, 2024
Dyne Therapeutics reported fiscal year 2023 executive compensation information on April 5, 2024.
In 2023, three executives at Dyne Therapeutics received on average a compensation package of $3.4M, a 17% increase compared to previous year.
Average pay of disclosed executives at Dyne Therapeutics
Josh Brumm, Chief Executive Officer, received $6M in total, which increased by 38% compared to 2022. 65% of Brumm's compensation, or $3.9M, was in stock awards. Brumm also received $460K in non-equity incentive plan, $965K in option awards, $644K in salary, as well as $996 in other compensation.
Jonathan McNeill, Chief Business Officer, received a compensation package of $2.2M. 47% of the compensation package, or $1M, was in stock awards.
Susanna High, Chief Operating Officer, earned $2M in 2023, a 28% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 5, 2024.